| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000046658 |
| Receipt No. | R000051750 |
| Scientific Title | Follow-Up study of paTients UndeRgoing cathEter ablation for Atrial Fibrillation: evaluation of long-term outcomes and predictive factors based on genetic predisposition |
| Date of disclosure of the study information | 2022/01/17 |
| Last modified on | 2022/01/17 (Ver. 1) |
| Basic information | ||
| Public title | Follow-Up study of paTients UndeRgoing cathEter ablation for Atrial Fibrillation: evaluation of long-term outcomes and predictive factors based on genetic predisposition
|
|
| Acronym | FUTURE-AF Study | |
| Scientific Title | Follow-Up study of paTients UndeRgoing cathEter ablation for Atrial Fibrillation: evaluation of long-term outcomes and predictive factors based on genetic predisposition
|
|
| Scientific Title:Acronym | FUTURE-AF Study | |
| Region |
|
|
| Condition | ||
| Condition | atrial fibrillation | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | To evaluate whether genetic markers or genetic risk scores for atrial fibrillation predict the incidence of cardiovascular events and recurrence of atrial fibrillation at 36 months after atrial fibrillation ablation in a Japanese population |
| Basic objectives2 | Others |
| Basic objectives -Others | Cross-sectional evaluation of the association of single-nucleotide polymorphisms with clinical background and electrophysiological factors. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Association between genetic markers or genetic risk scores and cardiovascular events at 36 months post catheter ablation |
| Key secondary outcomes | Association between genetic markers or genetic risk scores and atrial fibrillation recurrence at 36 months post catheter ablation
Association between genetic markers or genetic risk scores and implantation of cardiac devices at 36 months post catheter ablation Association between genetic markers or genetic risk scores and clinical backgrounds Association between genetic markers or genetic risk scores and echocardiographic data Association between genetic markers or genetic risk scores and electrocardiographic findings Association between genetic markers or genetic risk scores and electrophysiological findings Association of genetic markers, genetic risk scores with clinical scores such as CHADS2 score, CHA2DS2-Vasc score, HASBLED score and comparison of the performance between the scores Genome-wide association analysis using study participants as atrial fibrillation cases Association of blood biomarkers with genetic markers and genetic risk scores Association between blood biomarkers and atrial tachyarrhythmia recurrence rate at 36 months post catheter ablation Association between blood biomarkers and cardiovascular events at 36 months post catheter ablation |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Patients who undergo radiofrequency catheter ablation for atrial fibrillation during the period from the approval of the ethical review of clinical research to December 31, 2026.
(2) Age 20 years or older |
|||
| Key exclusion criteria | Patients who are judged by the attending physician to be unsuitable for participation in the study | |||
| Target sample size | 5000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Saga University Hospital | ||||||
| Division name | Department of Cardiovascular Medicine | ||||||
| Zip code | 849-8501 | ||||||
| Address | 5-1-1Nabeshima,Saga | ||||||
| TEL | 0952342443 | ||||||
| takanori@cc.saga-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Saga University Hospital | ||||||
| Division name | Department of Cardiovascular Medicine | ||||||
| Zip code | 849-8501 | ||||||
| Address | 5-1-1Nabeshima,Saga | ||||||
| TEL | 0952342443 | ||||||
| Homepage URL | |||||||
| takanori@cc.saga-u.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Cardiovascular Medicine, Saga University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Cardiovascular Medicine, Saga University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | CLINICAL RESEARCH CENTER,SAGA UNIVERSITY HOSPITAL |
| Address | 5-1-1Nabeshima,Saga |
| Tel | 0952343400 |
| kenkyu-shinsei@ml.cc.saga-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大分大学医学部循環器内科・臨床検査診断学講座(大分)
佐賀県医療センター好生館循環器内科(佐賀) 嬉野医療センター循環器内科(佐賀) 済生会二日市病院循環器内科(福岡) 東京大学医学部附属病院循環器内科(東京) 理化学研究所生命医科学研究センター(神奈川) 国立長寿医療研究センターメディカルゲノムセンター(愛知) 京都大学医学部附属病院循環器内科(京都) 県立広島病院循環器内科(広島) 三菱京都病院心臓内科(京都) 医療法人札幌ハートセンター札幌心臓血管クリニック循環器内科(北海道) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | The incidence of cardiovascular events and recurrence of atrial fibrillation will be evaluated at 36 months post catheter ablation |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051750 |